前收市價 | 86.45 |
開市 | 87.20 |
買盤 | 0.00 x 1100 |
賣出價 | 0.00 x 800 |
今日波幅 | 85.38 - 87.06 |
52 週波幅 | 60.57 - 96.12 |
成交量 | |
平均成交量 | 4,026,537 |
市值 | 51.639B |
Beta 值 (5 年,每月) | 1.07 |
市盈率 (最近 12 個月) | 37.30 |
每股盈利 (最近 12 個月) | 2.30 |
業績公佈日 | 2024年4月25日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 94.28 |
Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
Molina's (MOH) first-quarter performance is likely to have been hurt by escalating medical care costs, partly offset by growing membership in all three businesses.